SentreHEART

SentreHEART, Inc. is a private medical device company that produces the LARIAT(R) Suture Delivery Device for the remote delivery of pre-tied sutures. Regulatory approvals for soft tissue ligation and approximation procedures have been obtained in the United States, Europe, and Canada. SentreHEART is committed to the development of clinical evidence and is currently sponsoring the FDA-approved prospective, multicenter, randomized controlled trial known as the aMAZE Trial. This trial aims to demonstrate the added benefits of LARIAT LAA closure in conjunction with pulmonary vein isolation as a means to improve outcomes for patients with persistent or long-standing persistent atrial fibrillation.